ClinicalTrials.Veeva

Menu

Compare the Clinical Efficacy of Prototype Toothpastes

Colgate-Palmolive logo

Colgate-Palmolive

Status and phase

Completed
Phase 3

Conditions

Dental Plaque

Treatments

Drug: Triclosan, fluoride
Drug: Fluoride
Other: Metal salt

Study type

Interventional

Funder types

Industry

Identifiers

NCT00926029
CRO-2007-GIN-06-RR

Details and patient eligibility

About

Clinical study to compare the clinical efficacy of toothpastes on dental plaque and gingival inflammation.

Enrollment

98 patients

Sex

All

Ages

18 to 65 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male or female volunteers 18-65 years of age.
  • Good general health.
  • Must sign informed consent form.
  • Minimum of 20 natural uncrowned teeth (excluding third molars) must be present.
  • No history of allergy to personal care consumer products, or their ingredients, relevant to any ingredient in the test products as determined by the dental/medical professional monitoring the study.

Exclusion criteria

  • Subject unable or unwilling to sign the informed consent form.
  • Medical condition which requires pre-medication prior to dental visits/procedures.
  • Moderate or advanced periodontal disease.
  • 5 or more decayed untreated dental sites at screening.
  • Other disease of the hard or soft oral tissues.
  • Impaired salivary function (e.g. Sjogren's syndrome or head and neck irradiation).
  • Use of medications that currently affect salivary flow.
  • Use of antibiotics or antimicrobial drugs within 30 days prior to study visit #1.
  • Pregnant or nursing women.
  • Participation in any other clinical study within 1 week prior to enrollment into this study.
  • Use of tobacco products.
  • Subjects who must receive dental treatment during the study dates.
  • Current use of Antibiotics for any purpose.
  • Presence of an orthodontic appliance.
  • History of allergy to common dentifrice ingredients.
  • History of allergy to zinc.
  • Immune compromised individuals (HIV, AIDS, immuno suppressive drug therapy).

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

98 participants in 3 patient groups, including a placebo group

Fluoride control -A
Placebo Comparator group
Description:
Winterfresh Gel
Treatment:
Drug: Fluoride
Triclosan/Fluoride - B
Active Comparator group
Description:
Positive control (Total toothpaste)
Treatment:
Drug: Triclosan, fluoride
Triclosan/fluoride/metal salt- C
Experimental group
Description:
test toothpaste
Treatment:
Other: Metal salt

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems